These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 38755195)

  • 1. Mediterranean diet as a strategy for preserving kidney function in patients with coronary heart disease with type 2 diabetes and obesity: a secondary analysis of CORDIOPREV randomized controlled trial.
    Podadera-Herreros A; Arenas-de Larriva AP; Gutierrez-Mariscal FM; Alcala-Diaz JF; Ojeda-Rodriguez A; Rodriguez-Cantalejo F; Cardelo MP; Rodriguez-Cano D; Torres-Peña JD; Luque RM; Ordovas JM; Perez-Martinez P; Delgado-Lista J; Lopez-Miranda J; Yubero-Serrano EM
    Nutr Diabetes; 2024 May; 14(1):27. PubMed ID: 38755195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term consumption of a mediterranean diet or a low-fat diet on kidney function in coronary heart disease patients: The CORDIOPREV randomized controlled trial.
    Podadera-Herreros A; Alcala-Diaz JF; Gutierrez-Mariscal FM; Jimenez-Torres J; Cruz-Ares S; Arenas-de Larriva AP; Cardelo MP; Torres-Peña JD; Luque RM; Ordovas JM; Delgado-Lista J; Lopez-Miranda J; Yubero-Serrano EM
    Clin Nutr; 2022 Feb; 41(2):552-559. PubMed ID: 35030530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mediterranean diet and endothelial function in patients with coronary heart disease: An analysis of the CORDIOPREV randomized controlled trial.
    Yubero-Serrano EM; Fernandez-Gandara C; Garcia-Rios A; Rangel-Zuñiga OA; Gutierrez-Mariscal FM; Torres-Peña JD; Marin C; Lopez-Moreno J; Castaño JP; Delgado-Lista J; Ordovas JM; Perez-Martinez P; Lopez-Miranda J
    PLoS Med; 2020 Sep; 17(9):e1003282. PubMed ID: 32903262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal function following three distinct weight loss dietary strategies during 2 years of a randomized controlled trial.
    Tirosh A; Golan R; Harman-Boehm I; Henkin Y; Schwarzfuchs D; Rudich A; Kovsan J; Fiedler GM; Blüher M; Stumvoll M; Thiery J; Stampfer MJ; Shai I
    Diabetes Care; 2013 Aug; 36(8):2225-32. PubMed ID: 23690533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduction of circulating methylglyoxal levels by a Mediterranean diet is associated with preserved kidney function in patients with type 2 diabetes and coronary heart disease: From the CORDIOPREV randomized controlled trial.
    Gutierrez-Mariscal FM; Podadera-Herreros A; Alcalá-Diaz JF; Cardelo MP; Arenas-de Larriva AP; Cruz-Ares S; Torres-Peña JD; Luque RM; Perez-Martinez P; Delgado-Lista J; Lopez-Miranda J; Yubero-Serrano EM
    Diabetes Metab; 2024 Jan; 50(1):101503. PubMed ID: 38097011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mediterranean Diet Reduces Atherosclerosis Progression in Coronary Heart Disease: An Analysis of the CORDIOPREV Randomized Controlled Trial.
    Jimenez-Torres J; Alcalá-Diaz JF; Torres-Peña JD; Gutierrez-Mariscal FM; Leon-Acuña A; Gómez-Luna P; Fernández-Gandara C; Quintana-Navarro GM; Fernandez-Garcia JC; Perez-Martinez P; Ordovas JM; Delgado-Lista J; Yubero-Serrano EM; Lopez-Miranda J
    Stroke; 2021 Nov; 52(11):3440-3449. PubMed ID: 34372670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Telomere length as biomarker of nutritional therapy for prevention of type 2 diabetes mellitus development in patients with coronary heart disease: CORDIOPREV randomised controlled trial.
    Ojeda-Rodriguez A; Rangel-Zuñiga OA; Arenas-de Larriva AP; Gutierrez-Mariscal FM; Torres-Peña JD; Romero-Cabrera JL; Podadera-Herreros A; García-Fernandez H; Porras-Pérez E; Luque RM; Kales SN; Perez-Martinez P; Delgado-Lista J; Yubero-Serrano EM; Lopez-Miranda J
    Cardiovasc Diabetol; 2024 Mar; 23(1):98. PubMed ID: 38493287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Dapagliflozin on Cardiovascular Outcomes According to Baseline Kidney Function and Albuminuria Status in Patients With Type 2 Diabetes: A Prespecified Secondary Analysis of a Randomized Clinical Trial.
    Zelniker TA; Raz I; Mosenzon O; Dwyer JP; Heerspink HHJL; Cahn A; Goodrich EL; Im K; Bhatt DL; Leiter LA; McGuire DK; Wilding JPH; Gause-Nilsson I; Langkilde AM; Sabatine MS; Wiviott SD
    JAMA Cardiol; 2021 Jul; 6(7):801-810. PubMed ID: 33851953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of dapagliflozin on the rate of decline in kidney function in patients with chronic kidney disease with and without type 2 diabetes: a prespecified analysis from the DAPA-CKD trial.
    Heerspink HJL; Jongs N; Chertow GM; Langkilde AM; McMurray JJV; Correa-Rotter R; Rossing P; Sjöström CD; Stefansson BV; Toto RD; Wheeler DC; Greene T;
    Lancet Diabetes Endocrinol; 2021 Nov; 9(11):743-754. PubMed ID: 34619108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediabetes diagnosis criteria, type 2 diabetes risk and dietary modulation: The CORDIOPREV study.
    Roncero-Ramos I; Alcala-Diaz JF; Rangel-Zuñiga OA; Gomez-Delgado F; Jimenez-Lucena R; García-Rios A; Vals-Delgado C; Romero-Baldonado C; Luque RM; Ordovas JM; Perez-Martinez P; Camargo A; Lopez-Miranda J
    Clin Nutr; 2020 Feb; 39(2):492-500. PubMed ID: 30852029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CORonary Diet Intervention with Olive oil and cardiovascular PREVention study (the CORDIOPREV study): Rationale, methods, and baseline characteristics: A clinical trial comparing the efficacy of a Mediterranean diet rich in olive oil versus a low-fat diet on cardiovascular disease in coronary patients.
    Delgado-Lista J; Perez-Martinez P; Garcia-Rios A; Alcala-Diaz JF; Perez-Caballero AI; Gomez-Delgado F; Fuentes F; Quintana-Navarro G; Lopez-Segura F; Ortiz-Morales AM; Delgado-Casado N; Yubero-Serrano EM; Camargo A; Marin C; Rodriguez-Cantalejo F; Gomez-Luna P; Ordovas JM; Lopez-Miranda J; Perez-Jimenez F
    Am Heart J; 2016 Jul; 177():42-50. PubMed ID: 27297848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduction in Circulating Advanced Glycation End Products by Mediterranean Diet Is Associated with Increased Likelihood of Type 2 Diabetes Remission in Patients with Coronary Heart Disease: From the Cordioprev Study.
    Gutierrez-Mariscal FM; Cardelo MP; de la Cruz S; Alcala-Diaz JF; Roncero-Ramos I; Guler I; Vals-Delgado C; López-Moreno A; Luque RM; Delgado-Lista J; Perez-Martinez P; Yubero-Serrano EM; Lopez-Miranda J
    Mol Nutr Food Res; 2021 Jan; 65(1):e1901290. PubMed ID: 32529753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Associations of Early Kidney Disease With Brain Magnetic Resonance Imaging and Cognitive Function in African Americans With Type 2 Diabetes Mellitus.
    Freedman BI; Sink KM; Hugenschmidt CE; Hughes TM; Williamson JD; Whitlow CT; Palmer ND; Miller ME; Lovato LC; Xu J; Smith SC; Launer LJ; Barzilay JI; Cohen RM; Sullivan MD; Bryan RN; Wagner BC; Bowden DW; Maldjian JA; Divers J;
    Am J Kidney Dis; 2017 Nov; 70(5):627-637. PubMed ID: 28648301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between Diet Quality and Risk of Type 2 Diabetes Mellitus in Patients with Coronary Heart Disease: Findings from the CORDIOPREV Study.
    Rivas-Garcia L; Quintana-Navarro GM; Alcala-Díaz JF; Torres-Peña JD; Arenas-de Larriva AP; Rangel-Zuñiga OA; López-Moreno A; Malagon MM; Katsiki N; Perez-Martinez P; Lopez-Miranda J; Delgado-Lista J
    Nutrients; 2024 Apr; 16(8):. PubMed ID: 38674939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiRNAs profile as biomarkers of nutritional therapy for the prevention of type 2 diabetes mellitus: From the CORDIOPREV study.
    Jimenez-Lucena R; Alcala-Diaz JF; Roncero-Ramos I; Lopez-Moreno J; Camargo A; Gomez-Delgado F; Quintana-Navarro GM; Vals-Delgado C; Rodriguez-Cantalejo F; Luque RM; Delgado-Lista J; Ordovas JM; Perez-Martinez P; Rangel-Zuñiga OA; Lopez-Miranda J
    Clin Nutr; 2021 Mar; 40(3):1028-1038. PubMed ID: 32723508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dietary strategies for patients with type 2 diabetes in the era of multi-approaches; review and results from the Dietary Intervention Randomized Controlled Trial (DIRECT).
    Ben-Avraham S; Harman-Boehm I; Schwarzfuchs D; Shai I
    Diabetes Res Clin Pract; 2009 Dec; 86 Suppl 1():S41-8. PubMed ID: 20115931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beta cell functionality and hepatic insulin resistance are major contributors to type 2 diabetes remission and starting pharmacological therapy: from CORDIOPREV randomized controlled trial.
    Roncero-Ramos I; Gutierrez-Mariscal FM; Gomez-Delgado F; Villasanta-Gonzalez A; Torres-Peña JD; Cruz-Ares S; Rangel-Zuñiga OA; Luque RM; Ordovas JM; Delgado-Lista J; Perez-Martinez P; Camargo A; Alcalá-Diaz JF; Lopez-Miranda J
    Transl Res; 2021 Dec; 238():12-24. PubMed ID: 34298148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Association Between Kidney Disease and Diabetes Remission in Bariatric Surgery Patients With Type 2 Diabetes.
    Friedman AN; Wang J; Wahed AS; Docherty NG; Fennern E; Pomp A; Purnell JQ; le Roux CW; Wolfe B
    Am J Kidney Dis; 2019 Dec; 74(6):761-770. PubMed ID: 31331758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of cystatin C- and creatinine-based estimated glomerular filtration rate to predict coronary heart disease risk in Japanese patients with obesity and diabetes.
    Ito R; Yamakage H; Kotani K; Wada H; Otani S; Yonezawa K; Ogo A; Okajima T; Adachi M; Araki R; Yoshida K; Saito M; Nagaoka T; Toyonaga T; Tanaka T; Yamada T; Ota I; Oishi M; Miyanaga F; Shimatsu A; Satoh-Asahara N;
    Endocr J; 2015; 62(2):201-7. PubMed ID: 25399862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kidney disease progression and all-cause mortality across estimated glomerular filtration rate and albuminuria categories among patients with vs. without type 2 diabetes.
    Nichols GA; Déruaz-Luyet A; Brodovicz KG; Kimes TM; Rosales AG; Hauske SJ
    BMC Nephrol; 2020 May; 21(1):167. PubMed ID: 32380961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.